343 related articles for article (PubMed ID: 34777333)
1. The Dynamic Immunological Parameter Landscape in Coronavirus Disease 2019 Patients With Different Outcomes.
Tang G; Huang M; Luo Y; Liu W; Lin Q; Mao L; Wu S; Xiong Z; Hou H; Sun Z; Wang F
Front Immunol; 2021; 12():697622. PubMed ID: 34777333
[TBL] [Abstract][Full Text] [Related]
2. A systematic meta-analysis of immune signatures in patients with COVID-19.
Liu K; Yang T; Peng XF; Lv SM; Ye XL; Zhao TS; Li JC; Shao ZJ; Lu QB; Li JY; Liu W
Rev Med Virol; 2021 Jul; 31(4):e2195. PubMed ID: 34260780
[TBL] [Abstract][Full Text] [Related]
3. The laboratory tests and host immunity of COVID-19 patients with different severity of illness.
Wang F; Hou H; Luo Y; Tang G; Wu S; Huang M; Liu W; Zhu Y; Lin Q; Mao L; Fang M; Zhang H; Sun Z
JCI Insight; 2020 May; 5(10):. PubMed ID: 32324595
[TBL] [Abstract][Full Text] [Related]
4. Dynamic changes in lymphocyte subsets and parallel cytokine levels in patients with severe and critical COVID-19.
Liu Y; Tan W; Chen H; Zhu Y; Wan L; Jiang K; Guo Y; Tang K; Xie C; Yi H; Kuang Y; Luo Y
BMC Infect Dis; 2021 Jan; 21(1):79. PubMed ID: 33461503
[TBL] [Abstract][Full Text] [Related]
5. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
Front Immunol; 2021; 12():700921. PubMed ID: 34539631
[TBL] [Abstract][Full Text] [Related]
6. Different Innate and Adaptive Immune Responses to SARS-CoV-2 Infection of Asymptomatic, Mild, and Severe Cases.
Carsetti R; Zaffina S; Piano Mortari E; Terreri S; Corrente F; Capponi C; Palomba P; Mirabella M; Cascioli S; Palange P; Cuccaro I; Milito C; Zumla A; Maeurer M; Camisa V; Vinci MR; Santoro A; Cimini E; Marchioni L; Nicastri E; Palmieri F; Agrati C; Ippolito G; Porzio O; Concato C; Onetti Muda A; Raponi M; Quintarelli C; Quinti I; Locatelli F
Front Immunol; 2020; 11():610300. PubMed ID: 33391280
[TBL] [Abstract][Full Text] [Related]
7. Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity.
Kulkarni-Munje A; Palkar S; Shrivastava S; Lalwani S; Mishra AC; Arankalle VA
Immun Inflamm Dis; 2021 Jun; 9(2):419-434. PubMed ID: 33452858
[TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets.
Matic S; Popovic S; Djurdjevic P; Todorovic D; Djordjevic N; Mijailovic Z; Sazdanovic P; Milovanovic D; Ruzic Zecevic D; Petrovic M; Sazdanovic M; Zornic N; Vukicevic V; Petrovic I; Matic S; Karic Vukicevic M; Baskic D
PLoS One; 2020; 15(12):e0241097. PubMed ID: 33382687
[TBL] [Abstract][Full Text] [Related]
9. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
Front Immunol; 2020; 11():596684. PubMed ID: 33362779
[TBL] [Abstract][Full Text] [Related]
10. Relationship between the dynamic changes of serum 2019-nCoV IgM/IgG and patient immunity after 6 month hospital discharge.
Shen Y; Ba Y; Hu Y; Wang L; Li W
Inflamm Res; 2021 Feb; 70(2):241-247. PubMed ID: 33385239
[TBL] [Abstract][Full Text] [Related]
11. A Longitudinal Study of Immune Cells in Severe COVID-19 Patients.
Payen D; Cravat M; Maadadi H; Didelot C; Prosic L; Dupuis C; Losser MR; De Carvalho Bittencourt M
Front Immunol; 2020; 11():580250. PubMed ID: 33178207
[TBL] [Abstract][Full Text] [Related]
12. Mild Cytokine Elevation, Moderate CD4
Jia R; Wang X; Liu P; Liang X; Ge Y; Tian H; Chang H; Zhou H; Zeng M; Xu J
Virol Sin; 2020 Dec; 35(6):734-743. PubMed ID: 32699972
[TBL] [Abstract][Full Text] [Related]
13. Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19.
Jiménez-Cortegana C; Liró J; Palazón-Carrión N; Salamanca E; Sojo-Dorado J; de la Cruz-Merino L; Pascual Á; Rodríguez-Baño J; Sánchez-Margalet V
Viral Immunol; 2021 Nov; 34(9):639-645. PubMed ID: 34529510
[TBL] [Abstract][Full Text] [Related]
14. Unique immunological profile in patients with COVID-19.
Varchetta S; Mele D; Oliviero B; Mantovani S; Ludovisi S; Cerino A; Bruno R; Castelli A; Mosconi M; Vecchia M; Roda S; Sachs M; Klersy C; Mondelli MU
Cell Mol Immunol; 2021 Mar; 18(3):604-612. PubMed ID: 33060840
[TBL] [Abstract][Full Text] [Related]
15. Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients.
Tomić S; Đokić J; Stevanović D; Ilić N; Gruden-Movsesijan A; Dinić M; Radojević D; Bekić M; Mitrović N; Tomašević R; Mikić D; Stojanović D; Čolić M
Front Immunol; 2021; 12():614599. PubMed ID: 33692788
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19.
Kazancioglu S; Yilmaz FM; Bastug A; Sakallı A; Ozbay BO; Buyuktarakci C; Bodur H; Yilmaz G
Viral Immunol; 2021 Jun; 34(5):342-351. PubMed ID: 33264073
[TBL] [Abstract][Full Text] [Related]
17. Elevated frequencies of CD14
Xue G; Jiang M; Zhao R; Le A; Li J
Aging (Albany NY); 2021 Feb; 13(5):6236-6246. PubMed ID: 33640878
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and Cancer: Discovery of Difference in Clinical Immune Indexes.
Zeng X; Jiang X; Yang L; Pan Y; Li Y
J Immunol Res; 2021; 2021():8669098. PubMed ID: 34712741
[TBL] [Abstract][Full Text] [Related]
19. Characteristics of immune cells and cytokines in patients with coronavirus disease 2019 in Guangzhou, China.
Chen X; Huang J; Huang Y; Chen J; Huang Y; Jiang X; Shi Y
Hum Immunol; 2020 Dec; 81(12):702-708. PubMed ID: 32950268
[TBL] [Abstract][Full Text] [Related]
20. The dynamics of immune response in COVID-19 patients with different illness severity.
Zhang B; Yue D; Wang Y; Wang F; Wu S; Hou H
J Med Virol; 2021 Feb; 93(2):1070-1077. PubMed ID: 32910461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
